AXSM vs WELL · rev $409.6M vs P/E 100, rev $10.84B
Axsome Therapeutics Inc (AXSM) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
AXSM currently screens at market cap $11.96B. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the AXSM and WELL stock pages for the full models.
Not investment advice.